Corcept Therapeutics Incorporated shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Corcept Therapeutics Incorporated by Connor, Clark & Lunn Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $40M | 860k | 46.28 |
2024-06-30 | $23M | 716k | 32.49 |
2024-03-31 | $14M | 542k | 25.19 |
2023-12-31 | $12M | 361k | 32.48 |
2023-09-30 | $9.9M | 362k | 27.25 |
2023-06-30 | $8.1M | 363k | 22.25 |
2023-03-31 | $4.8M | 221k | 21.66 |
2022-12-31 | $2.8M | 139k | 20.31 |
2022-09-30 | $2.1M | 82k | 25.64 |
2022-06-30 | $1.8M | 75k | 23.79 |
2022-03-31 | $3.1M | 138k | 22.52 |
2021-12-31 | $952k | 48k | 19.79 |
2021-09-30 | $233k | 12k | 19.66 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated